Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program

Cannabics Pharmaceuticals, Inc. announced the launching of a new research program for the development of a breast cancer antitumor targeting medicine following the successful completion of a series of preclinical experiments.